Pharmaceutical

Global funding cuts reversing decades of tuberculosis p...

Ahead of World Tuberculosis Day on 24 March, the WHO has said that global fundin...

How to manage regulatory complexities with clinical tri...

Clinical trials must use effective electronic data capture platforms that priori...

Menarini to enhance BPDCN detection with VisualDx’s link

Menarini Group has announced a partnership with VisualDx to enhance the diagnosi...

Funding drought: how can biotech and biopharma keep tri...

Biotech and biopharma companies have battled with a drought of private investmen...

Pfizer sells 7.3% stake in Haleon for $3.3bn

Pfizer has divested its residual shareholding in Haleon, representing 7.3% of th...

Oxford BioTherapeutics and Roche link on antibody cance...

OBT has entered a multi-year partnership with Roche to discover antibody-based t...

Blood cancers dominate CAR-T pipeline

Among the 13 CAR-T therapeutics that have received regulatory approval are Gilea...

USPTO allows patents for Remedy’s large hemispheric inf...

The US Patent and Trademark Office (USPTO) has allowed two new patents for Remed...

FDA approves Johnson & Johnson’s Tremfya to treat Crohn...

J&J has received US FDA approval for Tremfya (guselkumab), to treat moderately t...

Sanofi outlays $1.9bn to purchase Dren Bio’s bispecific...

Sanofi’s move for Dren Bio’s clinical asset boosts its immunology-focused strate...

Servier and Black Diamond sign deal for solid tumours t...

Servier and Black Diamond Therapeutics have signed a licencing agreement for tar...

International Reference Pricing (IRP) 2024: A year in r...

A key trend seen in 2024 and recent years is the simplification of basket sizes,...

Roche’s discontinued Alzheimer’s drug shows signs of pr...

Investigators said that the OLE study showed Roche’s gantenerumab dropped the ri...

Health Canada approves Biogen’s Skyclarys for Friedreic...

Health Canada has granted approval for Biogen’s Skyclarys to treat Friedreich’s ...

Big tech meets biotech: Recursion and the AI gold rush ...

The use of AI in drug discovery and development has been recognised, explored, a...